← All claims

Sweeteners · Diets

dietary sugar increases cancer risk

In plain terms: Does eating sugar feed cancer?

Leans support Sweeteners

Part of: • Added sugar

RefutedContestedStrong support
consensus score 0.33

Not the way the myth suggests. Tumours do run on glucose — but so does every cell in your body, and cutting sugar from your plate doesn't starve a tumour; your body keeps blood glucose steady regardless. What the human data does show is a weak association between high sugar intake and some cancers, and it runs mostly through obesity and excess calories rather than sugar feeding tumours directly. The evidence is observational and largely mixed, so this sits barely above the line.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Population patterns (Observational)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

3 support 0 contradict 0 tested null 5 mixed · 8 sources, 3 independent groups

What the evidence shows

The popular 'sugar feeds cancer — cut it to starve tumours' claim is not supported. All cells run on glucose and the body tightly defends blood-sugar levels, so you cannot selectively starve a tumour by cutting dietary sugar, and umbrella reviews rate direct sugar–cancer evidence as weak/low-quality.

The evidence (13)

SourceGradeStanceQualityFinding
Zhao L, Zhang X, Coday M, Garcia DO, Li X, Mossavar-Rahmani Y, Naughton MJ, Lopez-Pentecost M, Saquib N, Shadyab AH, Simon MS, Snetselaar LG, Tabung FK, Tobias DK, VoPham T, McGlynn KA, Sesso HD, Giovannucci E, Manson JE, Hu FB, Tinker LF, Zhang X
2023 · JAMA
observational mixed moderate JAMA cohort: sugar-sweetened beverages associated with higher liver-cancer and chronic-liver-disease mortality — an obesity/metabolic-mediated association, not direct tumour feeding.
Singh D, Liu J, Luo J, Huang L, Huang QS, Yang L, Zhou Z
2026 · Nutrition and health
observational supports low Analysis of 53,914 PLCO trial participants found higher eriodictyol intake (mainly from citrus/sugar-sweetened orange beverages) associated with increased colorectal cancer risk, particularly in diabetic/hyperglycemic patients, via LASSO re
Watling CZ, Zhao L, Zhang X, Deubler E, Gonzalez-Feliciano AG, Graubard BI, Petrick JL, Wojt A, Butera G, Hofmann JN, Beane Freeman LE, Shrubsole MJ, Zheng W, Sudenga SL, Schernhammer E, Eliassen AH, Mucci LA, Sesso HD, Sinha R, Loftfield E, Um CY, McCullough ML, Jenab M, Zhang X, McGlynn KA
2026 · JAMA Netw Open
observational supports moderate Pooled analysis of 11 prospective cohorts (n=1,518,411; 2,811 liver cancers; 1,699 HCC, 444 ICC). 'SSB intake per 1-beverage/day increase was not associated with overall liver cancer risk but was associated with increased risk of HCC (HR, 1.10; 95% CI, 1.03-1.18; 10 cohorts) and ICC (HR, 1.15; 95% CI, 1.00-1.32; 6 cohorts).' Subtype estimates come from 10 and 6 cohorts respectively, not all 11. SSB is a proxy for dietary sugar (soda, sugary beverages, juice), and the association is adjusted for BMI and diabetes; the paper does not test a direct tumour-feeding mechanism.
Yu Y, Dai C, Ling R
2026 · Clinical breast cancer
observational mixed low NHANES cross-sectional cluster analysis (PCA + k-means) of diet-physical-activity patterns found the lowest breast cancer prevalence cluster had low sugar intake plus high work activity and moderate fiber; findings are confounded by combine
Malik VS, Hu FB
2022 · Nat Rev Endocrinol
observational mixed moderate Nat Rev Endocrinol: SSBs drive obesity and chronic disease (incl. some cancers) chiefly through weight gain/metabolic pathways.
Monteiro Dos Santos JE, Araújo MC, Passos da Silva CMF
2026 · Scientific reports
observational mixed low Brazilian ecological study using state-level dietary survey and cancer registry data found the 'Western' dietary pattern (soft drinks, sweetened beverages, snacks, candies) associated with higher colorectal cancer incidence in men (IRR 1.02
Chi Y, Lin B, Sun S, Zhang H, Lin C, Zhang Z
2026 · Genes, chromosomes & cancer
observational mixed moderate Two-sample Mendelian randomization using GWAS data found nominal positive association of genetically-predicted sugar-in-tea intake with CRC risk (OR 1.307) that did not survive FDR correction; GrimAge epigenetic-aging acceleration partly me
Thakur BK, Choudhury SR, Turpin W, Martin A
2026 · Gut microbes
observational supports low Narrative review on diet-microbiome interactions in colorectal carcinogenesis: pro-inflammatory, low-fiber Western diets (implicitly including high sugar) foster mucosal inflammation and genotoxic microbial niches; no isolated dietary-sugar
Rahman A, Hussain T, Afroz M, Rahman S, Mridha MK, Shamim AA, Akter F
2026 · BMJ public health
observational mixed low PRISMA systematic review (17 studies, 276,825 participants) of ultra-processed food and gastric cancer risk found sugary beverages among several UPF categories inconsistently associated with increased risk (8/17 positive, 3 null, 6 mixed)
Tian Y, Geng G, Xie P, Song J
2026 · International dental journal
observational supports low Global population-attributable-fraction analysis (185 countries, 1990-2018) found sugar-sweetened beverages had the highest harmful population attributable fraction (+36.1%) for oral cancer, with SSB PAF rising over time alongside a 56% inc
Dawson KL, Waddell O, Frizelle F, Keenan JI
2026 · N Z Med J
observational mixed low Viewpoint, not evidence: 'This viewpoint also considers whether reductions in SSB consumption could represent a simple and potentially impactful strategy'. Argues sugar-driven metabolic dysregulation 'may' contribute to EOCRC; no data. Review — zero weight.
Huang Y, Chen Z, Chen B, Li J, Yuan X, Li J, Wang W, Dai T, Chen H, Wang Y, Wang R, Wang P, Guo J, Dong Q, Liu C, Wei Q, Cao D, Liu L
2023 · BMJ
meta-analysis mixed moderate Umbrella review of meta-analyses: 'The search identified 73 meta-analyses'; harmful associations with 'seven cancer outcomes', e.g. fructose +25 g/day and pancreatic cancer, 'low quality evidence' (class III). Observational; no tumour-feeding mechanism tested. Review — zero weight.
Tratnjek L, Janev A, Kuret T, Jerman UD
2026 · Frontiers in immunology
observational mixed low Narrative review synthesizing mechanistic (elevated glucose promotes bladder cancer cell proliferation/EMT in vitro) and epidemiological evidence (heterogeneous associations of high dietary glycaemic index/sugar with bladder cancer risk), e

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.